DCM
PROF

DAFNA Capital Management’s Profound Medical PROF Stock Holding History

DAFNA Capital Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.7M Sell
263,005
-22,705
-8% -$157K 0.39% 49
2025
Q4 		$2.25M Buy
+285,710
New +$1.84M 0.52% 46

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

DAFNA Capital Management's PROF Position: Q1 2026 in Review

DAFNA Capital Management reduced its Profound Medical (PROF) stake by 7.9% in Q1 2026, selling an estimated $157K and leaving 263,005 shares worth $1.7M. The position accounts for 0.39% of the portfolio, ranked #49.

DAFNA Capital Management first reported a position in PROF in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.25M in Q4 2025. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • DAFNA Capital Management held 263,005 shares of Profound Medical worth $1.7M as of Q1 2026.
  • DAFNA Capital Management sold 22,705 Profound Medical shares in Q1 2026, an estimated $157K.
  • Profound Medical made up 0.39% of DAFNA Capital Management's portfolio in Q1 2026, its #49 holding.
  • DAFNA Capital Management first reported a position in Profound Medical in Q4 2025 and has held it in 2 quarters since.
  • DAFNA Capital Management's Profound Medical position peaked at $2.25M in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on DAFNA Capital Management's 13F filing for Q1 2026, filed 15 May 2026.